3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole has been researched along with Schizophrenia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bailey, CD; Chung, BY; Cloke, JM; De Lisio, S; Kim, JC; Nguyen, R; Wasserman, DI; Winters, BD | 1 |
1 other study(ies) available for 3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole and Schizophrenia
| Article | Year |
|---|---|
A Novel Multisensory Integration Task Reveals Robust Deficits in Rodent Models of Schizophrenia: Converging Evidence for Remediation via Nicotinic Receptor Stimulation of Inhibitory Transmission in the Prefrontal Cortex.
Topics: Animals; gamma-Aminobutyric Acid; In Vitro Techniques; Isoxazoles; Ketamine; Male; Mice; Mice, Inbred C57BL; Nicotinic Agonists; Prefrontal Cortex; Psychomotor Performance; Pyrrolidines; Rats; Rats, Long-Evans; Receptors, Nicotinic; Schizophrenia; Schizophrenic Psychology; Synaptic Transmission | 2016 |